Hellweg H, Hartung H D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role of NGF in the pathogenesis of diabetic neuropathy [J].J Neurosci Res,1990,26 (2):258.
[7]
Brewster W J, Fernyhough P, Lara T, et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors [J]. TINS, 1994, 17(8): 321.
Murakawa Y, Zhang W,Hewn C R,et a1.Impaired glucose tolerance an dinsulinopenia in the GK-rat causes peripheral neuropathy [J].Diabetes Metab Res Rev,2002,18:473.
[11]
Rask C A. Biological actions of nerve growth factor in the peripheral nervous system [J]. Eur Neurol, 1999,41(Suppl 1):14.
[12]
Hellweg R, Raivich G, Hartung H D, et al. Axonal transport of endogenous nerve growth factor (NGF) and NGF reception in experimental diabetic neuropathy [J]. Exp Neurol, 1994,130(1):24.
[13]
Unger J W, Klitzsch T, Pera S, Reiter R. Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphologial investigations of the sural nerve, dorsal root ganglion, and spinal cord [J]. Exp Neurol, 1998, 153(1):23.
[14]
Dyck P J, Larson T S, O\'Brien P C, et al. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts. Nerve growth factor study group [J]. Diabetes Care, 2000,23(4):510.
[15]
Apfel S C,Schwartz S,Adrnato B T,et a1.Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy [J].J Am Med Assot,2000,284(17):2215.
